| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Vascular Biology Program, Institute for Cell Engineering; Departments of Pediatrics, Medicine, Oncology, and Radiation Oncology; and McKusick-Nathans Institute for Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and 2 Microvascular and Molecular Neuro-Oncology Laboratory, Departments of Pathology and Neurosurgery, New York University Cancer Institute of New York University School of Medicine, New York, New York
Requests for reprints: Gregg L. Semenza, Johns Hopkins University School of Medicine, Broadway Research Building, 733 North Broadway, Suite 671, Baltimore, MD 21205. Fax: 443-287-5618; E-mail: gsemenza{at}jhmi.edu.
A critical event in the pathogenesis of invasive and metastatic cancer is E-cadherin loss of function. Renal clear cell carcinoma (RCC) is characterized by loss of function of the von Hippel-Lindau tumor suppressor (VHL), which negatively regulates hypoxia-inducible factor-1 (HIF-1). Loss of E-cadherin expression and decreased cell-cell adhesion in VHL-null RCC4 cells were corrected by enforced expression of VHL, a dominant-negative HIF-1
mutant, or a short hairpin RNA directed against HIF-1
. In human RCC biopsies, expression of E-cadherin and HIF-1
was mutually exclusive. The expression of mRNAs encoding TCF3, ZFHX1A, and ZFHX1B, which repress E-cadherin gene transcription, was increased in VHL-null RCC4 cells in a HIF-1dependent manner. Thus, HIF-1 contributes to the epithelial-mesenchymal transition in VHL-null RCC by indirect repression of E-cadherin. (Cancer Res 2006; 66(5): 2725-31)
This article has been cited by other articles:
![]() |
T. Liu, C. P. Masamha, S. Chengedza, K. D. Berlin, S. Lightfoot, F. He, and D. M. Benbrook Development of flexible-heteroarotinoids for kidney cancer Mol. Cancer Ther., May 1, 2009; 8(5): 1227 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wacker, M. Sachs, K. Knaup, M. Wiesener, J. Weiske, O. Huber, Z. Akcetin, and J. Behrens Key Role for Activin B in Cellular Transformation after Loss of the von Hippel-Lindau Tumor Suppressor Mol. Cell. Biol., April 1, 2009; 29(7): 1707 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scortegagna, R. J. Martin, R. D. Kladney, R. G. Neumann, and J. M. Arbeit Hypoxia-Inducible Factor-1{alpha} Suppresses Squamous Carcinogenic Progression and Epithelial-Mesenchymal Transition Cancer Res., March 15, 2009; 69(6): 2638 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Harten, D. Shukla, R. Barod, A. Hergovich, M. S. Balda, K. Matter, M. A. Esteban, and P. H. Maxwell Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin Mol. Biol. Cell, February 1, 2009; 20(3): 1089 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zheng, J. Kuhlicke, K. Jackel, H. K. Eltzschig, A. Singh, M. Sjoblom, B. Riederer, C. Weinhold, U. Seidler, S. P. Colgan, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium FASEB J, January 1, 2009; 23(1): 204 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Does Loss of CD151 Expression Promote the Metastasis of Hypoxic Colon Cancer Cells? Clin. Cancer Res., December 15, 2008; 14(24): 7969 - 7970. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feijoo-Cuaresma, F. Mendez, A. Maqueda, M. A. Esteban, S. Naranjo-Suarez, M. C. Castellanos, M. H. del Cerro, S. N. Vazquez, A. Garcia-Pardo, M. O. Landazuri, et al. Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells J. Biol. Chem., September 5, 2008; 283(36): 24982 - 24990. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Frew and W. Krek pVHL: A Multipurpose Adaptor Protein Sci. Signal., June 17, 2008; 1(24): pe30 - pe30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beltran, I. Puig, C. Pena, J. M. Garcia, A. B. Alvarez, R. Pena, F. Bonilla, and A. G. de Herreros A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition Genes & Dev., March 15, 2008; 22(6): 756 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Hypoxia-inducible Factor 1 and Human Cancer ASCO Educational Book, January 1, 2008; 2008(1): 548 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheel, T. Onder, A. Karnoub, R. A. Weinberg, and J. E. Talmadge Adaptation versus Selection: The Origins of Metastatic Behavior Cancer Res., December 15, 2007; 67(24): 11476 - 11480. [Full Text] [PDF] |
||||
![]() |
X. Xia, T. Rasmussen, X. Alvarez, T. Taguchi, M. Li, and V. F. La Russa Fluorescence In Situ Hybridization Using an Old World Monkey Y Chromosome specific Probe Combined With Immunofluorescence Staining on Rhesus Monkey Tissues J. Histochem. Cytochem., November 1, 2007; 55(11): 1115 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-w. Kim, P. Gao, Y.-C. Liu, G. L. Semenza, and C. V. Dang Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 Mol. Cell. Biol., November 1, 2007; 27(21): 7381 - 7393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mejlvang, M. Kriajevska, C. Vandewalle, T. Chernova, A. E. Sayan, G. Berx, J. K. Mellon, and E. Tulchinsky Direct Repression of Cyclin D1 by SIP1 Attenuates Cell Cycle Progression in Cells Undergoing an Epithelial Mesenchymal Transition Mol. Biol. Cell, November 1, 2007; 18(11): 4615 - 4624. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, C. Sloss, X. Zhang, S. W. Lee, and J. C. Cusack Membrane-Bound Heparin-Binding Epidermal Growth Factor Like Growth Factor Regulates E-Cadherin Expression in Pancreatic Carcinoma Cells Cancer Res., September 15, 2007; 67(18): 8486 - 8493. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, L. Zhang, X. Zhang, Q. Yan, Y. A. Minamishima, A. F. Olumi, M. Mao, S. Bartz, and W. G. Kaelin Jr. Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations Mol. Cell. Biol., August 1, 2007; 27(15): 5381 - 5392. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lester, M. Jo, V. Montel, S. Takimoto, and S. L. Gonias uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells J. Cell Biol., July 24, 2007; 178(3): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Kaelin Jr. The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma Clin. Cancer Res., January 15, 2007; 13(2): 680s - 684s. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Evans, R. C. Russell, O. Roche, T. N. Burry, J. E. Fish, V. W. K. Chow, W. Y. Kim, A. Saravanan, M. A. Maynard, M. L. Gervais, et al. VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail Mol. Cell. Biol., January 1, 2007; 27(1): 157 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Baffled by Bafilomycin: An Anticancer Agent That Induces Hypoxia-Inducible Factor-1{alpha} Expression Mol. Pharmacol., December 1, 2006; 70(6): 1841 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, S.-Y. Wang, A. C. Nottke, J. V. Rocheleau, D. W. Piston, and R. H. Goodman Redox sensor CtBP mediates hypoxia-induced tumor cell migration PNAS, June 13, 2006; 103(24): 9029 - 9033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Garcia HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies Sci. Signal., May 30, 2006; 2006(337): pe25 - pe25. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Melillo and G. L. Semenza Meeting Report: Exploiting the Tumor Microenvironment for Therapeutics. Cancer Res., May 1, 2006; 66(9): 4558 - 4560. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |